Page last updated: 2024-10-22

amsacrine and Cardiomyopathies, Primary

amsacrine has been researched along with Cardiomyopathies, Primary in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Research Excerpts

ExcerptRelevanceReference
"Amsacrine is an antileukemia drug being widely used in North America, Europe, Australia, and New Zealand."5.06Amsacrine-associated cardiotoxicity: an analysis of 82 cases. ( Grillo-López, AJ; Hess, F; Marsoni, S; Posada, JG; Ross, BJ; Weiss, RB, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weiss, RB1
Grillo-López, AJ1
Marsoni, S1
Posada, JG1
Hess, F1
Ross, BJ1

Trials

1 trial available for amsacrine and Cardiomyopathies, Primary

ArticleYear
Amsacrine-associated cardiotoxicity: an analysis of 82 cases.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:6

    Topics: Adolescent; Aminoacridines; Amsacrine; Antineoplastic Agents; Arrhythmias, Cardiac; Cardiomyopathies

1986